Board Meeting Of The Company Was Held On 14.11.2018 To Approve The Unaudited Financial Results For The Quarter Ended On 30.09.2018

Safal Herbs Ltd. manufactures medical and health products.  The Company manufactures herbal cosmetic, ayurvedic, consumer, and pharmaceutical products.  Parikh Herbals also provides research and development for new types of medicine.

Financial Results For The Quarter Ended On 30.09.2018

SAFAL HERBS LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve BOARD MEETING FOR APPROVAL OF FINANCIAL RESULTS FOR QUARTER ENDED 30.09.2018 WILL BE HELD ON 14.11.2018

Board Meeting Intimation For Intimation Of Board Meeting

Submission Of Compliance Certificate Under Regulation 40 (9) For The Half Year Ended On September, 2018

Compliance Under Regulation 40 (9) For The Half Year Ended On September, 2018

Submission Of Compliance Certificate Under Regulation 7 (3) For The Half Year Ended On September, 2018

Compliance Certificate Under Regulation 7 (3) For The Half Year Ended On September, 2018

Annual General Meeting of the company was held today at 12:00 pm

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Safal Herbs Ltd (SAHL IN)

Financial Results For The Quarter Ended On 30.09.2018

Board Meeting Intimation For Intimation Of Board Meeting

Compliance Under Regulation 40 (9) For The Half Year Ended On September, 2018

Compliance Certificate Under Regulation 7 (3) For The Half Year Ended On September, 2018

Announcement Under Regulation 30 (Lodr) -Meeting Updates

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)